000045839 000__ 01102nam\a2200337\i\4500
000045839 001__ 45839
000045839 003__ SzGeWIPO
000045839 005__ 20240708150216.0
000045839 006__ m\\\\eo\\d\\\\\\\\
000045839 007__ cr bn |||m|||a
000045839 008__ 220408s2021\\\\enk\\\\\o\\\\\000\0\eng\d
000045839 022__ $$a0018-9855
000045839 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO
000045839 041__ $$aeng
000045839 24500 $$aProduct, medicinal product, basic patent: the relationship of concepts in Regulation 469/2009 overlooked by the CJEU
000045839 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2021
000045839 300__ $$a1 online resource
000045839 337__ $$acomputer$$2rdamedia
000045839 4901_ $$aInternational Review of Intellectual Property Law & Competition Law,$$vVolume 52,
000045839 4901_ $$xIssue 10 ;
000045839 542__ $$fhttps://1.next.westlaw.com/Copyright
000045839 588__ $$aCrossref
000045839 590__ $$aPublished online: 2021
000045839 650_0 $$aIntellectual property
000045839 650_0 $$aPatent law$$vEurope
000045839 650_0 $$aMedical technology
000045839 7001_ $$aSzczepanowska-Kozlowska, Krystyna,$$eauthor.
000045839 7731_ $$tInternational Review of Intellectual Property Law & Competition Law
000045839 7731_ $$wIIC
000045839 830_0 $$aInternational Review of Intellectual Property Law & Competition Law ;$$vIIC 2021, 52(10), 1292-1313
000045839 85641 $$uhttps://www.westlaw.com/Document/I3DE68BF0759C11ECB5C1867853CAD37D/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000045839 904__ $$aJournal article
000045839 980__ $$aIIC